{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:18:17Z","timestamp":1780582697945,"version":"3.54.1"},"publisher-location":"Berlin, Heidelberg","reference-count":23,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642701429","type":"print"},{"value":"9783642701405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/978-3-642-70140-5_14","type":"book-chapter","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T18:06:39Z","timestamp":1319565999000},"page":"111-117","source":"Crossref","is-referenced-by-count":10,"title":["Medical Treatment of Dystonia"],"prefix":"10.1007","author":[{"given":"H.","family":"Pakkenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.33.6.802","volume":"33","author":"PH Altrocchi","year":"1983","unstructured":"Altrocchi PH, Forno LS (1983) Spontaneous oral-facial dyskinesia: Neuropathology of a case. Neurology 33: 802\u2013805","journal-title":"Neurology"},{"key":"14_CR2","first-page":"189","volume-title":"Experimental therapeutics of movement disorders","author":"R Burke","year":"1983","unstructured":"Burke R, Fahn S (1983) Double-blind evaluation of trihexyphenidyl in dystonia. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 189\u2013192"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(82)92856-2","volume":"1","author":"RE Burke","year":"1982","unstructured":"Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J (1982) Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet 1: 1299","journal-title":"Lancet"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.30.7.690","volume":"30","author":"DE Casey","year":"1980","unstructured":"Casey DE (1980) Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology 30: 690\u2013695","journal-title":"Neurology"},{"key":"14_CR5","first-page":"177","volume-title":"Experimental therapeutics of movement disorders","author":"S Fahn","year":"1983","unstructured":"Fahn S (1983a) High-dosage anticholinergic therapy in dystonia. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 177\u2013188"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/WNL.33.10.1255","volume":"33","author":"S Fahn","year":"1983","unstructured":"Fahn S (1983b) High dosage anticholinergic therapy in dystonia. Neurology 33: 1255\u20131261","journal-title":"Neurology"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0447.1964.tb05731.x","volume":"40","author":"A Faurbye","year":"1964","unstructured":"Faurbye A, Rasch PJ, Bender Petersen P, Brandborg G, Pakkenberg H (1964) Neurological symptoms in pharmacotherapy of psychosis. Acta Psychiatry Scand 40: 10\u201327","journal-title":"Acta Psychiatry Scand"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1600-0404.1970.tb05621.x","volume":"46","author":"R Fog","year":"1970","unstructured":"Fog R, Pakkenberg H (1970) Combined nitoman-pimozide treatment of Huntington\u2019s chorea and other hyperkinetic syndromes. Acta Neurol Scand 46: 249\u2013251","journal-title":"Acta Neurol Scand"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jnnp.44.5.437","volume":"44","author":"E Garcia-Albea","year":"1981","unstructured":"Garcia-Albea E, Franch O, Munoz D, Recoy JR (1981) Brueghel\u2019s syndrome, report of a case with postmortem studies. J Neurol Neurosurg Psychiatry 44: 437\u2013440","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR10","first-page":"207","volume-title":"Experimental therapeutics of movement disorders","author":"SM Gollomp","year":"1983","unstructured":"Gollomp SM, Fahn S, Bush R, Recher A, Ilson J (1983) Therapeutic trial in Meige\u2019s syndrome. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 207\u2013214"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ana.410130406","volume":"13","author":"J Jankovic","year":"1983","unstructured":"Jankovic J, Ford J (1983) Blepharospasm and orofacialcervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 13: 402\u2013411","journal-title":"Ann Neurol"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0317167100044139","volume":"9","author":"AE Lang","year":"1982","unstructured":"Lang AE, Sheehy MP, Marsden CD (1982) Anticholinergics in adult-onset focal dystonia. J Can Sci Neurol 9: 313\u2013319","journal-title":"J Can Sci Neurol"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","volume":"37","author":"CD Marsden","year":"1976","unstructured":"Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel\u2019s syndrome). J Neurol Neurosurg Psychiatry 37: 1204\u20131209","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR14","first-page":"81","volume-title":"Disorders of movement","author":"CD Marsden","year":"1981","unstructured":"Marsden CD (1981) Treatment of torsion dystonia. In: Barbeau A (ed) Disorders of movement. MTP Press, Lancaster, pp 81\u2013104"},{"key":"14_CR15","first-page":"191","volume-title":"Movement disorders","author":"CD Marsden","year":"1982","unstructured":"Marsden CD, Fahn S (1982) Problems in dyskinesias. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 191\u2013195"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.33.8.1100","volume":"33","author":"CD Marsden","year":"1983","unstructured":"Marsden CD, Lang AE, Sheehy MP (1983) Pharmacology of cranial dystonia. Neurology 33: 1100\u20131101","journal-title":"Neurology"},{"key":"14_CR17","first-page":"201","volume":"37","author":"JG Nutt","year":"1983","unstructured":"Nutt JG, Hammerstad JP, Carter JH, DeGarmo P (1983) Meige\u2019s syndrome: treatment with trihexiphenidyl. Adv Neurol 37: 201\u2013205","journal-title":"Adv Neurol"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.33.7.825","volume":"33","author":"JA Obeso","year":"1983","unstructured":"Obeso JA, Rothwell JC, Lange AE, Marsden CD (1983) Myoclonic dystonia. Neurology 33: 825\u2013830","journal-title":"Neurology"},{"key":"14_CR19","first-page":"3078","volume":"144","author":"B Pakkenberg","year":"1982","unstructured":"Pakkenberg B, Regeur L, Fog R, Pakkenberg H (1982) Gilles de la Tourette\u2019s syndrom. Ugeskr Laeger 144: 3078\u20133080","journal-title":"Ugeskr Laeger"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/WNL.32.8.889","volume":"32","author":"SM Stahl","year":"1982","unstructured":"Stahl SM, Berger PA (1982) Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias. Neurology 32: 889\u2013892","journal-title":"Neurology"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/WNL.32.7.783","volume":"32","author":"CM Tanner","year":"1982","unstructured":"Tanner CM, Glantz RH, Klawans HL (1982) Meige\u2019s disease: acute and chronic cholinergic effects. Neurology 32: 783\u2013784","journal-title":"Neurology"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archneur.1981.00510030041005","volume":"38","author":"ES Tolosa","year":"1981","unstructured":"Tolosa ES (1981) Clinical features of Meige\u2019s disease. Arch Neurol 38: 147\u2013151","journal-title":"Arch Neurol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1982.00510190069027","volume":"39","author":"WJ Weiner","year":"1982","unstructured":"Weiner WJ, Nausieda PA (1982) Meige\u2019s syndrome during long-term dopaminergic therapy in Parkinson\u2019s disease. Arch Neurol 39: 451\u2013452","journal-title":"Arch Neurol"}],"container-title":["Psychopharmacology Supplementum","Dyskinesia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-70140-5_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:45:01Z","timestamp":1606257901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-70140-5_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"ISBN":["9783642701429","9783642701405"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-70140-5_14","relation":{},"ISSN":["0931-6795"],"issn-type":[{"value":"0931-6795","type":"print"}],"subject":[],"published":{"date-parts":[[1985]]}}}